Epidemiology of Vibrio parahaemolyticus Outbreaks, Southern Chile
Erika Harth1, Luis Matsuda, Cristina Hernández, Maria L. Rioseco, Jaime Romero, Narjol González-Escalona, Jaime Martínez-Urtaza, and Romilio T. Espejo
Author affiliations: Universidad de Chile, Santiago, Chile (E. Harth, L. Matsuda, J. Romero, R.T. Espejo); Secretaría Regional Ministerial de Salud, Puerto Montt, Chile (C. Hernández); Hospital Regional de Puerto Montt, Puerto Montt (M.L. Rioseco); Food and Drug Administration, College Park, Maryland, USA (N. González-Escalona); Universidad de Santiago de Compostela, Santiago de Compostela, Spain (J. Martínez-Urtaza); 1Current affiliation: Helmholtz Centre of Infection Research, Braunschweig, Germany.
Figure 1. Direct genome restriction enzyme analysis with NaeI of clinical isolates of Vibrio parahaemolyticus representative of the 5 patterns observed during the outbreaks in Puerto Montt, Chile, January and February, 2007. Lanes MW, 100-bp size ladder; lane 2, PMC38.7; lane 3, PMC60.7; lane 4, PMC53.7; lane 5, PMC75.7; lane 6, VpKX. (O3:K6 pandemic isolate).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.